Skip to search formSkip to main contentSkip to account menu

Dipeptidyl-Peptidase IV Inhibitors

Known as: Dipeptidyl-Peptidase 4 Inhibitors, Inhibitors, Dipeptidyl-Peptidase IV, Dipeptidyl Peptidase 4 Inhibitors 
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Burgeoning levels of diabetes are a major concern for dialysis services, as diabetes is now the most common cause of end-stage… 
Review
2008
Review
2008
The gliptins, a new class of oral drugs for type 2 diabietes mellitus, lower blood glucose levels by a novel mechanism: ie, by… 
2004
2004
The process of maturation of blood cells via hematopoiesis involves cytokines and their regulation by the serine proteases CD26… 
2002
2002
Recently, data were presented showing that metformin increased plasma active glucagon-like peptide (GLP)-1[7–36NH2… 
2001
2001
Abstract: T cells play a major role in inflammatory skin disorders such as psoriasis vulgaris and atopic dermatitis. They are… 
Highly Cited
1995
Highly Cited
1995
Dipeptidyl-peptidase IV (EC 3.4.14.5) also known as CD26 is a membrane-bound serine peptidase which cleaves N-terminal dipeptides… 
1992
1992
The rat thymocyte costimulating protein appears to be involved in the regulation of CD4-/CD8- thymocyte proliferation in vitro…